TTK Healthcare Ltd Share Price – NSE /  BSE

Diversified, Small Cap

TTK Healthcare announced that Girish Rao (DIN: 00073937) and Dr (Mrs) Vandana R Walvekar (DIN: 00059160) have completed their second and final term as Independent Directors and consequently ceased to be the Directors of the Company w.e.f. 22 August 2024.

Powered by Capital Market - Live News

Net profit of TTK Healthcare rose 101.53% to Rs 31.58 crore in the quarter ended June 2024 as against Rs 15.67 crore during the previous quarter ended June 2023. Sales rose 2.86% to Rs 207.90 crore in the quarter ended June 2024 as against Rs 202.12 crore during the previous quarter ended June 2023.

Powered by Capital Market - Live News

Revenue from operations increased 2.86% YoY to Rs 207.90 crore in Q1 FY25.

Profit before tax (PBT) jumped 97.72% YoY to Rs 40.79 crore during the quarter.

On segmental front, revenue from Animal Welfare stood at Rs 31.11 crore (up 14.25% YoY), revenue from consumer products was at Rs 73.14 crore (up 2.77%YoY), revenue from medical devices stood at Rs 24.57 crore (up 10.63%YoY) while revenue from protective devices stood at Rs 46.28 crore ( down 10.07% YoY) during the period under review.

TTK Healthcare distribution of Consumer Products, Animal Welfare Products, Food Products, Medical Devices and Protective Devices.

The scrip hit an all time high at Rs 1,800 in intraday today.

Powered by Capital Market - Live News

TTK Healthcare will hold a meeting of the Board of Directors of the Company on 2 August 2024.

Powered by Capital Market - Live News